BNP Paribas Financial Markets
ABVX icon

BNP Paribas Financial Markets’s Abivax ABVX Stock Holding History

BNP Paribas Financial Markets’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.09M Sell
15,710
-24,652
-61% -$2.79M ﹤0.01% 2766
2026
Q1 		$4.49M Buy
40,362
+37,345
+1,238% +$4.42M ﹤0.01% 2109
2025
Q4 		$407K Buy
3,017
+1,217
+68% +$133K ﹤0.01% 3682
2025
Q3 		$153K Sell
1,800
-8,870
-83% -$544K ﹤0.01% 4124
2025
Q2 		$81.6K Sell
10,670
-776
-7% -$5.06K ﹤0.01% 4080
2025
Q1 		$71.5K Sell
11,446
-7,798
-41% -$52.8K ﹤0.01% 4162
2024
Q4 		$141K Buy
19,244
+6,200
+48% +$57.1K ﹤0.01% 4040
2024
Q3 		$150K Buy
13,044
+5,900
+83% +$70.7K ﹤0.01% 3357
2024
Q2 		$94.4K Buy
7,144
+1,500
+27% +$21.4K ﹤0.01% 3305
2024
Q1 		$80.7K Buy
+5,644
New +$72.8K ﹤0.01% 3489

Other funds holding ABVX

TCG Crossover Management
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Vestal Point Capital
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Jupiter Topco
Jupiter Topco New York $245B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets's ABVX Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Abivax (ABVX) stake by 61% in Q2 2026, selling an estimated $2.79M and leaving 15,710 shares worth $2.09M. The position accounts for ﹤0.01% of the portfolio, ranked #2766.

BNP Paribas Financial Markets first reported a position in ABVX in Q1 2024 and has held it in 10 quarters since. The position peaked at $4.49M in Q1 2026. 304 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • BNP Paribas Financial Markets held 15,710 shares of Abivax worth $2.09M as of Q2 2026.
  • BNP Paribas Financial Markets sold 24,652 Abivax shares in Q2 2026, an estimated $2.79M.
  • Abivax made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #2766 holding.
  • BNP Paribas Financial Markets first reported a position in Abivax in Q1 2024 and has held it in 10 quarters since.
  • BNP Paribas Financial Markets's Abivax position peaked at $4.49M in Q1 2026.
  • 304 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.